| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 06/05/2007 | CA2529003A1 Neural crest stem cell and uses thereof |
| 05/31/2007 | WO2007060974A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/31/2007 | WO2007060810A1 Morpholine type cinnamide compound |
| 05/31/2007 | WO2007059612A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2631121A1 Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells |
| 05/31/2007 | CA2629745A1 Morpholine type cinnamide compound |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628476A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1789052A1 Composition and method for inducing or restoring locomotor functions in an animal |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/29/2007 | US7225083 Determination antagonist, moderators; three-dimensional models |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/24/2007 | WO2007059342A2 Random copolymer compositions for treating unwanted immune response |
| 05/24/2007 | WO2006116302A3 High-potency botulinum toxin formulations |
| 05/24/2007 | WO2000009653A3 Method of inhibiting cathepsin k |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/23/2007 | EP1037539B2 Method for accelerating protein digestion rate and its use |
| 05/23/2007 | CN1966033A Medicament for treating eyelid ptosis and myasthenia gravis and method for preparing same |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220582 Stem cells that transform to beating cardiomyocytes |
| 05/22/2007 | CA2524619A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/22/2007 | CA2325033C Use of ribose to treat fibromyalgia |
| 05/18/2007 | WO2007055804A2 Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| 05/18/2007 | CA2626352A1 Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/16/2007 | EP1465923B1 Corticotropin releasing factor receptor 2 agonists |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | CN1961859A Novel formulation of Tizanidine and derivative thereof and preparation method thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/15/2007 | US7217840 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
| 05/15/2007 | US7217687 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 05/15/2007 | US7217565 Contacting, binding to monoclonal antibodies; therapy for central nervous system disorders |
| 05/10/2007 | WO2007052561A1 Method for prevention of myocardial hypertrophy by inhibiting interaction between slim1 and usp, and agent for prevention of myocardial hypertrophy |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105918 Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis |
| 05/09/2007 | EP1782825A2 Treatment of glycogen storage diseases type II |
| 05/09/2007 | EP1782803A1 Coenzyme q10-containing composition |
| 05/09/2007 | EP1781332A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 05/09/2007 | EP1781108A2 Use of methyl pyruvate for the purpose of increasing muscle energy production |
| 05/09/2007 | EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314433C Chinese traditional medicine for treating Tourette |
| 05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | CA2552694A1 Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2310593C Metalloproteinase inhibitors |
| 05/08/2007 | CA2306837C Treatment of female sexual dysfunction |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007048228A1 Boron-containing compounds, uses and preparation thereof |
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070099270 Novel neurotrophic factors |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1552834B1 N-acetyl-l-pipecolic acid as neurotrophic factor production promoter |
| 05/02/2007 | EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 05/02/2007 | EP1414824B1 Novel anticonvulsant derivative salts |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
| 05/02/2007 | CN1313602C Use of recobimation human ciliary nerve nutrition factor in inhibiting adult sarcoblast natural differentiation |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211602 Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |